肠道微生物群-神经炎症轴:一种新的机制和治疗发症伴随性抑郁症的治疗点
Xiujuan Wang1,2,3, Mu Liu1,2,3, Liuzhao Cao1,3
1Department of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, 563003, China.
Brain, behavior, & immunity - health
|January 1, 2026
概括
肠道微生物群-神经炎症轴在中影响并发性抑郁症. 通过益生菌,益生菌或抗炎疗法准这种肠-大脑连接,有望改善和抑郁症症状.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 影响30-50%的伴随性抑郁症患者,增加死亡率和自杀风险.
- 肠道微生物群失调和中枢神经系统炎症通过微生物代谢物,免疫调节和迷走神经相互作用.
- 患者表现出肠道微生物群多样性和组成的改变,导致全身和神经炎症.
研究的目的:
- 系统地审查肠道微生物群-神经炎症轴在和并发性抑郁症中的病理机制.
- 探索针对这一轴的治疗潜力,以改善患者的治疗结果.
主要方法:
- 对现有文献进行系统审查.
- 分析多领域的数据.
- 探索针对肠-大脑轴的干预策略.
主要成果:
- 在中肠道微生物群失调促进炎症,加剧发作和抑郁症状.
- 神经炎症影响神经递质代谢,血脑屏障功能和神经可塑性,创造了一个恶性循环.
- 诸如益生菌,益生菌和抗炎疗法等干预措施显示出改善发作频率和情绪状态的潜力.
结论:
- 肠道微生物群-神经炎症轴是精确预防和治疗时伴随性抑郁症的新目标.
- 基于多个OMIC分析的个性化治疗计划正在推进.
- 需要进一步的研究来验证因果机制,并进行长期后续研究.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
Physiology of Enteric Nervous System and Gut Health
831
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
831
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
790
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
790
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Depressive Disorders: Etiology
408
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
408
Irritable Bowel Syndrome I: Introduction
885
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
885


